levocetirizine / Generic mfg.  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

   Remove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
levocetirizine / Generic mfg.
2018-003139-31: Efficacy and safety of levocetirizine alone or in combination with tranexamic acid in the treatment of spontaneous chronic urticaria. Efficacité et tolérance de la Lévocétirizine seule ou en association avec l’acide tranexamique dans le traitement de l’urticaire chronique spontanée.

Ongoing
3
80
Europe
Tranexamic Acid, levocetirizine, Capsule, EXACYL, LEVOCETIRIZINE MYLAN
CHU GRENOBLE ALPES, Ministry of Health
Chronique Spontaneous urticaria Urticaire chronique spontanée, Chronique Spontaneous urticaria Urticaire chronique spontanée, Diseases [C] - Immune System Diseases [C20]
 
 
ChiCTR2300072867: A double-blind, double dummy, randomized, multicentre, phase III study to evaluate efficacy and safety of bilastine 20 mg and levocetirizine 5 mg once daily for the treatment of chronic idiopathic urticaria

Completed
3
288
 
Bilastine 20 mg + Levocetirizine-like dummy placebo ;Levocetirizine 5 mg + Bilastine-like dummy placebo
Peking University People's Hospital; A. Menarini Asia-Pacific Holdings Pte Ltd, A. Menarini Asia-Pacific Holdings Pte Ltd.
chronic idiopathic urticaria
 
 
COURAGE, NCT03545464 / 2018-002308-15: COrticosteroids in acUte uRticAria in emerGency dEpartment

Recruiting
3
240
Europe
Placebo Oral Tablet, Cortancyl Oral Tablet, Levocetirizine Oral Tablet
Assistance Publique - Hôpitaux de Paris
Urticaria, Angiœdema
03/25
09/25

Download Options